Add another Item to this comparison Add Item |
|||
Basic Information | |||
Generic Name
|
Amphetamine And Dextroamphetamine | Dextroamphetamine | Dexmethylphenidate |
Class
|
Cns Stimulants | Cns Stimulants | Cns Stimulants |
Prescription Generic Available
|
Yes | Yes | Yes |
Pregnancy cat.
|
C(us) | C(us) | C(us) |
Approved Age
|
3 And Older | 3 And Older | 6 And Older |
Legal Status
|
Schedule I (ca) Schedule Ii (us) | Schedule Ii (us) | Schedule Ii (us) |
WADA Category
|
S6 - Stimulants | ||
Dependence Liability
|
High | High | High |
Excretion
|
Urinary | Urinary | Renal |
Possible Side Effects
|
Some Loss Of Appetite, Weight Loss, Sleep Problems, Irritability, Tics. | Some Loss Of Appetite, Weight Loss, Sleep Problems, Irritability, Tics. | Some Loss Of Appetite, Weight Loss, Sleep Problems, Irritability, Tics. |
0Comments
|
|||
Dosage, Usage and Forms | |||
Routes (of administration)
|
(medical) Oral, Insufflated, Intravenous | Oral | Oral |
Dosage
|
5–30 Mg Bid Or 5–60 Mg Q Am | 3-5: 2.5mg Qam–20 Mg Bid; 5- 16: 5 Mg Q Am–20 Mg Bid | 2.5 Mg Bid–10 Mg Bid |
Maximum daily dose
|
60 mg |
20 mg |
10 mg |
Duration
|
Intermediate-acting | Short-acting | Short-acting |
Duration - time
|
4-8 H | 3-5 H | 3-4 H |
Chemical Data | |||
Molecular mass (g/mol)
|
135.21 G/mol | 135.206 G/mol | 233.31 G/mol |
Half Life
|
10 Hours |
10 Hours |
4 Hours |
Formula
|
C9h13n | (c9h13n)2•h2so4 | C14h19no2 |
Bioavailability
|
Nasal 75%; Rectal 95-99%; Intravenous 100% | 22-25% |
|
Protein binding
|
15-40% |
12-15% |
|
Metabolism
|
Hepatic | Hepatic | Hepatic |
cancel